L01XG01 |
B |
Bortezomib - 3.5mg |
9498 |
76118/1 |
VELCADE |
3.5mg |
1 |
Injectable lyophilised powder for solution |
IV/SC |
Mersaco |
BSP Pharmaceuticals SpA |
Italy |
23,616,000 L.L |
19.35 |
D |
Janssen Cilag International NV |
Belgium |
2/4/2025 |
|
L01XG01 |
G |
Bortezomib - 3.5mg |
10328 |
138619/1 |
ALVOCADE |
3.5mg |
1 |
Injectable powder for solution |
IV/SC |
Lebiran SARL |
Nano Fanavaran Darouei Alvand Co (Nano Alvand) |
Iran |
14,169,600 L.L |
19.35 |
D |
Nano Fanavaran Darouei Alvand Co (Nano Alvand) |
Iran |
2/4/2025 |
|
L01XG01 |
G |
Bortezomib - 3.5mg |
9386 |
186162/13 |
BORCADE |
3.5mg |
1 |
Injectable lyophilised powder |
IV/SC |
Benta Trading Co s.a.l. |
Hetero Labs Limited, India for Benta SAL |
Lebanon |
11,020,381 L.L |
19.35 |
D |
|
|
2/4/2025 |
|
L01XG01 |
G |
Bortezomib - 3.5mg |
10687 |
189319/1 |
BORCADE |
3.5mg |
1 |
Injectable lyophilised powder |
IV/SC |
Benta Trading Co s.a.l. |
Manufactured by MSN Laboratories Private Ltd, India for Benta SAL |
Lebanon |
11,020,381 L.L |
19.35 |
D |
|
|
2/4/2025 |
|
L01XG01 |
G |
Bortezomib - 3.5mg |
9477 |
146117/1 |
BORTEZOMIB ACCORD |
3.5mg |
1 |
Injectable powder for solution |
IV/SC |
Mediterranean Pharmaceutical Company |
Accord Healthcare Limited |
UK |
13,007,658 L.L |
21.26 |
C |
Accord Healthcare Limited |
UK |
2/4/2025 |
|
L01XG01 |
G |
Bortezomib - 3.5mg |
10598 |
87420/1 |
BORTEZOMIB NEAPOLIS |
3.5mg |
1 |
Injectable lyophilised powder for solution |
IV/SC |
Medis Pharm Drugstore |
Neapolis Pharma |
Tunisia |
14,169,600 L.L |
19.35 |
D |
Neapolis Pharma |
Tunisia |
2/4/2025 |
|
L01XG01 |
G |
Bortezomib - 3.5mg |
11269 |
177320/1 |
BORTEZOMIB SPC |
3.5mg |
1 |
Injectable powder for solution |
IV/SC |
Advanced Healthcare Services SAL |
Pharmaline SAL Licensed by Sudair Pharma Company, KSA |
Lebanon |
15,743,401 L.L |
19.35 |
D |
|
|
2/4/2025 |
|
L01XG01 |
G |
Bortezomib - 3.5mg |
10819 |
96420/1 |
VELZOME |
3.5mg |
1 |
Injectable powder for solution |
IV/SC |
Khalil Fattal & Fils S.A.L. |
Salutas Pharma GmbH |
Germany |
16,531,112 L.L |
19.35 |
D |
Hexal AG |
Germany |
2/4/2025 |
|
L01XG01 |
G |
Bortezomib - 3.5mg |
10598/388 |
87420/1 |
BORTEZOMIB NEAPOLIS |
3.5mg |
1 |
Injectable lyophilised powder for solution |
IV/SC |
Medis Pharm Drugstore |
Neapolis Pharma |
Tunisia |
L.L |
19.35 |
D |
Neapolis Pharma |
Tunisia |
2/5/2024 |
|